A cross-sectional study of untreated depression and anxiety in cutaneous lupus erythematosus and dermatomyositis

      Mental health issues are not well described in cutaneous lupus erythematosus (CLE) and dermatomyositis (DM), even though patients with CLE and DM have decreased quality of life.
      • Goreshi R.
      • Chock M.
      • Foering K.
      • et al.
      Quality of life in dermatomyositis.
      • Klein R.
      • Moghadam-Kia S.
      • Taylor L.
      • et al.
      Quality of life in cutaneous lupus erythematosus.
      Mental disorders have an increased prevalence in dermatology patients, with 10.1% and 17.2% of dermatology outpatients having clinical depression and anxiety, respectively.
      • Dalgard F.J.
      • Gieler U.
      • Tomas-Aragones L.
      • et al.
      The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries.
      The aim of this cross-sectional study was to characterize mental health in CLE and DM and to determine the unmet need for and barriers to mental health care.
      To read this article in full you will need to make a payment
      AAD Member Login
      AAD Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Goreshi R.
        • Chock M.
        • Foering K.
        • et al.
        Quality of life in dermatomyositis.
        J Am Acad Dermatol. 2011; 65: 1107-1116
        • Klein R.
        • Moghadam-Kia S.
        • Taylor L.
        • et al.
        Quality of life in cutaneous lupus erythematosus.
        J Am Acad Dermatol. 2011; 64: 849-858
        • Dalgard F.J.
        • Gieler U.
        • Tomas-Aragones L.
        • et al.
        The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries.
        J Invest Dermatol. 2015; 135: 984-991
        • Kroenke K.
        • Spitzer R.L.
        The PHQ-9: a new depression diagnostic and severity measure.
        Psychiatr Ann. 2002; 32: 509-515
        • Kroenke K.
        • Spitzer R.L.
        • Williams J.B.W.
        • Monahan P.O.
        • Lowe B.
        Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection.
        Ann Intern Med. 2007; 146: 317-325